Evidence map›Paper›PMID 39519098›Full record

ArticleInternational journal of molecular sciences2024

Pancreatic Adenocarcinoma Up-Regulated Factor (PAUF) Transforms Human Monocytes into Alternative M2 Macrophages with Immunosuppressive Action.

Yeon Jeong Kim, Sitansu Sekhar Nanda, Fen Jiang, Seung Yeon Pyo, Jin-Yeong Han, Sang Seok Koh, Tae Heung Kang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yeon Jeong KimPrestige Biopharma IDC, Busan 46726, Republic of Korea.ORCID 0000-0002-9102-5136
Sitansu Sekhar NandaPrestige Biopharma IDC, Busan 46726, Republic of Korea.ORCID 0000-0002-7663-4830
Fen JiangPrestige Biopharma IDC, Busan 46726, Republic of Korea.
Seung Yeon PyoPrestige Biopharma IDC, Busan 46726, Republic of Korea.
Jin-Yeong HanDepartment of Laboratory Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.
Sang Seok KohPrestige Biopharma IDC, Busan 46726, Republic of Korea.
Tae Heung KangPrestige Biopharma IDC, Busan 46726, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) promote immune evasion, cancer cell proliferation, and metastasis. Ongoing research is focused on finding ways to prevent tumor growth by inhibiting TAM polarization, which has shown a correlation with unfavorable prognosis in clinical studies. Pancreatic adenocarcinoma up-regulated factor (PAUF) is a protein secreted from pancreatic cancer (PC) and acts as a TME modulator that affects the TME by acting on not only cancer cells but also stromal cells and immune cells. Tumor cells can evade the immune system by PAUF binding to Toll-like receptor (TLR) in monocytes, as this research shows. In this study, the examination centered around the recruitment of human monocytes by PAUF and the subsequent differentiation into macrophages. In an in vitro chemotaxis assay, PAUF induced chemotactic migration of TLR2-mediated monocytes. In addition, PAUF induced differentiation of monocytes into M2 macrophages, which was verified based on expressing surface markers and cytokines and morphological analysis. The inhibition of T cell proliferation and function was observed in differentiated M2 macrophages. To conclude, these findings indicate that PAUF functions as a promoter of cancer progression by regulating the recruitment and differentiation of macrophages within TMEs, ultimately causing immunosuppression.

Indexed as

Cell DifferentiationMacrophagesMonocytesPancreatic NeoplasmsTumor MicroenvironmentAdenocarcinomaCell Line, TumorCell ProliferationHumansIntercellular Signaling Peptides and ProteinsToll-Like Receptor 2Tumor-Associated MacrophagesIntercellular Signaling Peptides and ProteinsToll-Like Receptor 2ZG16B protein, humanM2 macrophagesPAUFTAMTLRTME

Identifiers

PMID39519098
PMCPMC11547018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.